A doctor prepares a dose of the Pfizer-BioNTech vaccine in Cologne, Germany, March 28, 2021. Source: Thilo Schmuelgen/Reuters.
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Children as young as 12 may soon be able to receive Pfizer’s COVID-19 vaccination, after a ruling by Australia’s drug watchdog
  • The Therapeutic Goods Association (TGA) announced its approval of the jab on Friday paving the way for 12- to 15-year-olds to get immunised
  • Although children are now approved for the jab, they won’t be included in the vaccine rollout until the government’s immunisation advisory panel signs off
  • Teenagers aged 16 and above are already approved to receive the Pfizer vaccine, however, those under 40 aren’t in line to receive the jab until the end of the year
  • Additionally, only those aged over 18 can opt to receive the AstraZeneca jab, as the immunisation isn’t recommended for those under 60

Children as young as 12 may soon be able to receive Pfizer’s COVID-19 vaccination, after a ruling by Australia’s drug watchdog.

The Therapeutic Goods Association (TGA) announced on Friday it had approved the jab being used in 12- to 15-year-olds.

The TGA said the decision came after a “careful evaluation of the available data” including clinical studies.

Despite the approval though, children and teenagers won’t be included in the vaccine rollout until the government’s immunisation advisory panel signs off.

The Australian Technical Advisory Group on Immunisation (ATAGI) was expected to make a decision on kids over 12 using the Pfizer vaccine next week.

If ATAGI approves the jab for those over 12, the Federal Health Minister said the government would prioritise those with pre-existing health conditions.

“Our plans are in place to roll out what is more likely, on the early advice I have, is that they will fast-track vaccines for 12- to 15-year-olds for their immunocompromised children or those with underlying health conditions,” Mr Hunt told Channel 7.

Teenagers aged 16 and above were already approved to receive the Pfizer vaccine, however, those under 40 weren’t in line to receive the jab until the end of the year.

Additionally, only those aged over 18 can currently opt to receive the AstraZeneca COVID-19 vaccine, as the immunisation isn’t recommended for those under 60.

ATAGI doesn’t recommend the AZ jab for younger generations due to the rare blood clotting risk associated with the vaccine.

More From The Market Online
AI concept

The great AI scare sell-off is still permeating Wall Street; a speculative blog from the not-so-distant future stands as the latest culprit

The ongoing tech sell-off in the United States, ironically driven by the larger AI thematic itself, continues to define
US and Aus flag

The XJO benefitted from geopolitical calm last week. New tariff fears perhaps feel more familiar

Last week, I wrote that the ASX200 was having a good week, where Australian investors were reacting to Australian earnings reports and how

Okay, so just where is gold heading? Experts say its nowhere near finishline yet

Leading industry, government and investment groups are still confident that the gold’s bull run is nowhere…
Koala share trading AI

The ASX 200 is up over 4% YTD. What EOY targets are floating around?

It’s been a pretty good year for the ASX200 so far, helped greatly by the ‘commodity supercycle’ narrative – which isn’t really a